CJC DAC-1295 2 mg x 5 Vials – Potencia

Potencia CJC DAC-1295 2 mg is a premium research peptide formulated with CJC-1295 DAC (Drug Affinity Complex), a long-acting Growth Hormone Releasing Hormone (GHRH) analogue extensively studied for its prolonged interaction with growth hormone signaling pathways. The addition of the Drug Affinity Complex (DAC) extends the peptide’s biological activity, making it a valuable research compound for investigations involving endocrine physiology, hormone regulation, receptor signaling, and peptide pharmacokinetics.

Each pack contains 5 lyophilized vials, with 2 mg of CJC DAC-1295 per vial, providing researchers with a convenient multi-vial format for advanced laboratory studies. Manufactured under stringent quality standards, Potencia CJC DAC-1295 delivers exceptional purity, stability, and consistency, ensuring reliable performance across peptide and endocrine research applications.

Designed for precision-driven scientific investigations, Potencia CJC DAC-1295 offers researchers a dependable platform for exploring growth hormone physiology, GHRH receptor biology, peptide pharmacology, cellular communication, and metabolic signaling in controlled laboratory environments.

Key Features

• Premium CJC DAC-1295 (Drug Affinity Complex) research peptide
• 2 mg of high-purity peptide per vial
• 5 lyophilized vials per pack
• Long-acting Growth Hormone Releasing Hormone (GHRH) analogue
• High-purity research-grade formulation
• Commonly studied in growth hormone and endocrine pathway research
• Suitable for investigations involving GHRH receptor signaling, peptide pharmacokinetics, and hormone regulation
• Manufactured under strict quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

CJC DAC-1295 is a modified analogue of Growth Hormone Releasing Hormone (GHRH) engineered with a Drug Affinity Complex (DAC) to prolong its biological activity. In laboratory research, it is extensively studied for its interaction with GHRH receptors and its ability to support investigations into sustained growth hormone signaling, endocrine physiology, peptide pharmacokinetics, and cellular communication. Researchers commonly utilize CJC DAC-1295 to explore long-acting peptide behavior, hormone regulation mechanisms, and growth factor-related biological pathways in controlled scientific environments.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredient: CJC DAC-1295 (Drug Affinity Complex) – 2 mg

Packaging: 5 Lyophilized Vials